Estrogen and progestin components of oral contraceptives: Relationship to vascular disease
- 1 May 1997
- journal article
- review article
- Published by Elsevier in Contraception
- Vol. 55 (5) , 267-272
- https://doi.org/10.1016/s0010-7824(97)00029-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Myocardial infarction in users of low-dose oral contraceptivesPublished by Wolters Kluwer Health ,1999
- Risk of acute myocardial infarction and low-dose combined oral contraceptivesThe Lancet, 1996
- Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study.Stroke, 1994
- Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case‐control studyBJOG: An International Journal of Obstetrics and Gynaecology, 1991
- ORAL CONTRACEPTIVE USE AND THE RISK OF MYOCARDIAL INFARCTIONAmerican Journal of Epidemiology, 1990
- Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.BMJ, 1989
- Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke CigarettesNew England Journal of Medicine, 1987
- Oral contraceptives and stroke: findings in a large prospective study.BMJ, 1984
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980